시장보고서
상품코드
1429442

세계의 유전자 치료 시장 보고서(2024년)

Gene Therapy Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

유전자 치료 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2028년에는 21.8%의 연평균 복합 성장률(CAGR)로 277억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 암 환자 증가, 고령화 인구 증가, 제약 분야의 R&D 지출 증가, 시장 내 유전자 치료의 중요성 증가와 관련이 있을 수 있습니다. 예측 기간 동안 주요 동향으로는 규제 당국의 승인 획득을 통한 사업 운영 개선, 전략적 제휴 및 제휴를 통한 사업 활동 강화, 전략적 인수를 통한 사업 역량 확대, 사업 확장을 통한 사업 역량 강화 등이 있습니다.

유전자 치료 시장은 암 및 기타 대상 질환의 발생률이 크게 증가함에 따라 효과적인 치료법이 필요해지면서 성장하고 있습니다. 전 세계 암 발병률 증가는 예측 기간 동안 유전자 치료제 시장 확대에 기여할 것으로 예상됩니다. 미국 암 협회는 2022년 1월 기준으로 미국에서 약 190만 명이 새로 암 진단을 받고 609,360명이 암으로 사망할 것으로 예상하고 있어 첨단 치료의 시급성을 강조하고 있습니다. 폐암, 전립선암, 장암, 여성 유방암은 전 세계 신규 암 발생의 43%를 차지합니다. 전 세계적으로 암 발생률이 증가함에 따라 세포 사멸을 유도하거나 암의 성장을 지연시키는 새로운 유전자를 도입하는 등 효과적인 치료법으로 유전자 치료에 대한 수요가 증가하고 있습니다.

헬스케어 산업에 대한 투자 증가는 유전자 치료 시장의 성장을 촉진할 것입니다. 헬스케어 산업에 대한 투자에는 의료 서비스, 의료기기 및 의약품 제조, 의료 보험 제공, 헬스케어 분야에 기여하는 기업에 대한 자금 배분 등이 포함됩니다. 이러한 투자는 유전자 치료 산업에서 매우 중요한 역할을 하는데, 제약회사들이 특허 포트폴리오를 강화하고 유리한 파트너십을 확보하기 위해 전략적으로 투자하기 때문입니다. 이러한 투자는 혁신적인 유전자 치료 제품 개발에 도움이 됩니다. 예를 들어, 메디케어 메디케이드 서비스 센터의 2021-2030년 국가 의료 지출(NHE) 보고서에 따르면, 2021-2030년 사이 국가 의료 지출은 연평균 5.1% 증가하여 6조 8,000억 달러에 육박할 것으로 예측됩니다. 메디케어 지출은 연평균 7.2%, 메디케이드 지출은 연평균 5.6% 증가할 것으로 예상되며, 메디케어 지출은 연평균 7.2% 증가할 것으로 예상됩니다. 따라서 헬스케어 산업에 대한 투자 증가는 유전자 치료 시장의 성장 동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 유전자 치료 시장, 유전자 치료 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 생식 세포계 치료
  • 체세포 치료
  • 세계의 유전자 치료 시장, 벡터별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 바이러스 벡터
  • 비바이러스 벡터
  • 세계의 유전자 치료 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 종양학
  • 희귀질환
  • 슬관절 골관절염
  • 신경학적 장애
  • 세계의 유전자 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 바이오의약품 기업
  • 연구기관
  • 기타 최종사용자

제7장 지역 및 국가 분석

  • 세계의 유전자 치료 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 유전자 치료 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 유전자 치료 시장 경쟁 상황
  • 유전자 치료 시장 기업 개요
    • UniQure NV
    • REGENXBIO Inc.
    • Bristol-Myers Squibb
    • BioMarin Pharmaceuticals Inc.
    • Jazz Pharmaceuticals Inc.

제31장 기타 주요 및 혁신적인 기업

  • Biocon
  • Cipla
  • EdiGene Inc
  • Takeda Pharmaceutical
  • Daiichi Sankyo Company
  • Mitsubishi Tanabe Pharma
  • Merck
  • GE Healthcare
  • Lonza
  • Pfizer
  • Cellular Biomedicine Group
  • GenScript
  • Albumedix Ltd
  • Catalent
  • Freeline Therapeutics

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Gene therapy is an approach to treating or curing diseases by modifying an individual's DNA. The mechanisms of gene treatments vary and may involve introducing a healthy copy of a gene to replace a disease-causing one or deactivating a defective gene responsible for an illness.

The primary types of gene therapy include germline therapy and somatic cell therapy. Germline therapy, also known as germline gene therapy, focuses on modifying the genes in germline cells-sperm and egg cells or their precursors. This type of genetic intervention aims to bring about changes at the hereditary level. Different vectors, such as viral vectors, non-viral vectors, and others, are utilized in gene therapy. The application of gene therapy extends to various sectors, including biopharmaceutical companies, research institutes, and other end users. It is employed in addressing conditions related to oncology, orphan diseases, knee osteoarthritis, and neurological disorders.

The gene therapy market research report is one of a series of new reports from The Business Research Company that provides gene therapy market statistics, including gene therapy industry global market size, regional shares, competitors with a gene therapy market share, detailed gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy industry. This gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gene therapy market size has grown exponentially in recent years. It will grow from $9.66 billion in 2023 to $12.64 billion in 2024 at a compound annual growth rate (CAGR) of 30.9%. The growth observed in the historical period can be ascribed to an increase in pharmaceutical research and development (R&D) spending, the escalation of public-private partnerships, government investments, and a rise in the incidence of spinal muscular atrophy.

The gene therapy market size is expected to see exponential growth in the next few years. It will grow to $27.77 billion in 2028 at a compound annual growth rate (CAGR) of 21.8%. The anticipated growth in the forecast period can be linked to a rise in cancer cases, the expanding aging population, increased research and development expenditure in the pharmaceutical sector, and a growing emphasis on gene therapy within the market. Key trends in the forecast period involve improving business operations by obtaining regulatory approvals, reinforcing business activities through strategic collaborations and partnerships, expanding business capabilities through strategic acquisitions, and enhancing operational capabilities through business expansions.

The gene therapy market is experiencing growth due to a significant increase in the incidence of cancer and other target diseases, necessitating effective treatments. The global rise in cancer cases is expected to contribute to the expansion of the gene therapy market in the forecast period. As of January 2022, the American Cancer Society predicts approximately 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the United States, highlighting the urgency for advanced treatments. Lung, prostate, bowel, and female breast cancer collectively account for 43 percent of all new cancer cases worldwide. The escalating global cancer incidence is poised to drive demand for gene therapy as an effective treatment, involving the introduction of new genes to induce cell death or slow cancer growth.

The increasing investment in the healthcare industry is set to fuel the growth of the gene therapy market. Healthcare industry investment encompasses allocating funds to companies involved in medical services, manufacturing medical equipment or drugs, offering medical insurance, and contributing to the healthcare sector. This investment plays a pivotal role in the gene therapy industry, as pharmaceutical companies strategically invest to enhance patent portfolios and secure lucrative partnerships. Such investments are instrumental in the development of innovative gene therapy products. For instance, based on the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, national health spending is projected to grow by an average of 5.1% annually, reaching nearly $6.8 trillion between 2021 and 2030. Moreover, Medicare spending is expected to increase at a 7.2% annual rate, while Medicaid spending is projected to rise by 5.6% annually. Hence, the increasing healthcare industry investment serves as a driving force behind the growth of the gene therapy market.

Machine learning and artificial intelligence (AI) are gradually gaining traction in the gene therapy market. AI involves simulating human intelligence in machines, Programd to exhibit natural intelligence. As a subset of AI, machine learning supports gene therapy companies in conducting comprehensive data analysis, providing insights into tumor and immune cell interactions, and delivering more accurate evaluations of tissue samples, resolving disputes among different evaluators. For example, in May 2023, Form Bio, a US-based life sciences-focused software company, introduced FORMsightAI, an innovative AI-based solution set designed to predict and optimize manufacturing outputs of cell and gene therapy constructs. This full-service solution combines adaptive AI models, Form Bio's foundational platform, and a proficient team of computational life sciences experts. FORMsightAI addresses common challenges faced by cell and gene therapy developers, including construct truncations and manufacturing contaminations, leading to improved manufacturing yields, shortened timelines to market, and enhanced therapeutic safety.

Major companies in the gene therapy market are strategically investing in the development of gene therapy facilities, such as innovation hubs, to gain a competitive advantage. Gene therapy facilities are specialized establishments for manufacturing and administering gene therapy products, aiming to correct underlying genetic issues and treat or prevent diseases. In March 2021, The Medical Research Council (MRC), LifeArc, and the Biotechnology and Biological Sciences Research Council in the UK announced substantial investments to establish a national network of cutting-edge gene therapy innovation hubs. Supported by $19 million in funding, these facilities aim to accelerate the clinical development of novel genetic therapies, potentially transforming the care of millions of patients, especially those with rare and fatal genetic disorders.

In December 2021, Novartis AG, a Swiss pharmaceutical company, acquired Gyroscope Therapeutics Holdings plc for $800 million. Through this acquisition, Novartis expands its gene therapy research capabilities by adding GT005, an experimental one-time gene therapy in Phase 2 for treating geographic atrophy (GA). This move enhances Novartis's commitment to ophthalmic innovation, contributing to the global effort to treat and prevent blindness related to eye diseases. Gyroscope Therapeutics Holdings PLC, based in the UK, is a clinical-stage biopharmaceutical company specializing in the research and development of gene therapies for eye-related diseases.

Major companies operating in the gene therapy market report are UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc., Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd., Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

North America was the largest region in the gene therapy market in 2023. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The gene therapy market includes revenues earned by entities by replacing a disease-causing gene with a healthy copy of the gene and inactivating a disease-causing gene that is not functioning properly. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy
  • 2) By Vector: Viral Vector; Non-Viral Vector
  • 3) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological Disorders
  • 4) By End Users: Biopharmaceutical Companies; Research Institutes; Other End Users
  • Companies Mentioned: UniQure NV; REGENXBIO Inc.; Bristol-Myers Squibb; BioMarin Pharmaceuticals Inc.; Jazz Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Therapy Market Characteristics

3. Gene Therapy Market Trends And Strategies

4. Gene Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gene Therapy Market Size and Growth

  • 5.1. Global Gene Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gene Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gene Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gene Therapy Market Segmentation

  • 6.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Germline Therapy
  • Somatic Cell Therapy
  • 6.2. Global Gene Therapy Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Viral Vector
  • Non-Viral Vector
  • 6.3. Global Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Orphan Disease
  • Knee Osteoarthritis
  • Neurological Disorders
  • 6.4. Global Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceutical Companies
  • Research Institutes
  • Other End Users

7. Gene Therapy Market Regional And Country Analysis

  • 7.1. Global Gene Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gene Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gene Therapy Market

  • 8.1. Asia-Pacific Gene Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gene Therapy Market

  • 9.1. China Gene Therapy Market Overview
  • 9.2. China Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gene Therapy Market

  • 10.1. India Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gene Therapy Market

  • 11.1. Japan Gene Therapy Market Overview
  • 11.2. Japan Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gene Therapy Market

  • 12.1. Australia Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gene Therapy Market

  • 13.1. Indonesia Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gene Therapy Market

  • 14.1. South Korea Gene Therapy Market Overview
  • 14.2. South Korea Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gene Therapy Market

  • 15.1. Western Europe Gene Therapy Market Overview
  • 15.2. Western Europe Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gene Therapy Market

  • 16.1. UK Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gene Therapy Market

  • 17.1. Germany Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gene Therapy Market

  • 18.1. France Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gene Therapy Market

  • 19.1. Italy Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gene Therapy Market

  • 20.1. Spain Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gene Therapy Market

  • 21.1. Eastern Europe Gene Therapy Market Overview
  • 21.2. Eastern Europe Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gene Therapy Market

  • 22.1. Russia Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gene Therapy Market

  • 23.1. North America Gene Therapy Market Overview
  • 23.2. North America Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gene Therapy Market

  • 24.1. USA Gene Therapy Market Overview
  • 24.2. USA Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gene Therapy Market

  • 25.1. Canada Gene Therapy Market Overview
  • 25.2. Canada Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gene Therapy Market

  • 26.1. South America Gene Therapy Market Overview
  • 26.2. South America Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gene Therapy Market

  • 27.1. Brazil Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gene Therapy Market

  • 28.1. Middle East Gene Therapy Market Overview
  • 28.2. Middle East Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gene Therapy Market

  • 29.1. Africa Gene Therapy Market Overview
  • 29.2. Africa Gene Therapy Market, Segmentation By Gene Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gene Therapy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gene Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Gene Therapy Market Competitive Landscape
  • 30.2. Gene Therapy Market Company Profiles
    • 30.2.1. UniQure NV
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. REGENXBIO Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bristol-Myers Squibb
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. BioMarin Pharmaceuticals Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Jazz Pharmaceuticals Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gene Therapy Market Other Major And Innovative Companies

  • 31.1. Biocon
  • 31.2. Cipla
  • 31.3. EdiGene Inc
  • 31.4. Takeda Pharmaceutical
  • 31.5. Daiichi Sankyo Company
  • 31.6. Mitsubishi Tanabe Pharma
  • 31.7. Merck
  • 31.8. GE Healthcare
  • 31.9. Lonza
  • 31.10. Pfizer
  • 31.11. Cellular Biomedicine Group
  • 31.12. GenScript
  • 31.13. Albumedix Ltd
  • 31.14. Catalent
  • 31.15. Freeline Therapeutics

32. Global Gene Therapy Market Competitive Benchmarking

33. Global Gene Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gene Therapy Market

35. Gene Therapy Market Future Outlook and Potential Analysis

  • 35.1 Gene Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gene Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gene Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제